Skip Navigation



Mutagenesis Advance Access published online on August 31, 2005

Mutagenesis, doi:10.1093/mutage/gei055
This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
20/6/411    most recent
gei055v2
gei055v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Çelik, A.
Right arrow Articles by Çömelekoglu, U.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Çelik, A.
Right arrow Articles by Çömelekoglu, U.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2005. Published by Oxford University Press on behalf of the UK Environmental Mutagen Society. All rights reserved. For permissions, please email: journals.permissions@oupjournals.org
Received June 6, 2005
Revised August 2, 2005
Accepted August 8, 2005

Original article

The evaluation of micronucleus frequency by acridine orange fluorescent staining in peripheral blood of rats treated with lead acetate

Ayla Çelik 1*, Oya Ögenler 2, and Ülkü Çömelekoglu 2

1 Department of Biology, Faculty of Science and Letters, Mersin University, Mersin, Turkey
2 Department of Biophysics, Faculty of Medicine, Mersin University, Mersin, Turkey

* To whom correspondence should be addressed.
Ayla Çelik, E-mail: a.celik{at}mersin.edu.tr


   Abstract

The data concerning the mutagenic, clastogenic and carcinogenic properties of inorganic lead compounds have been conflicting. Here, we evaluated the frequency of micronuclei in the peripheral blood of female rats treated with three different lead acetate doses. Outbred female Wistar rats were treated by gavage once per week for 10 weeks with cumulative doses of 140, 250 and 500 mg/kg body weight (body wt) of lead acetate. Mitomycin C (MMC) 2 mg/kg body wt was used as a positive control. The aim of the present study was to investigate the possible cytotoxic and genotoxic effects of lead acetate on peripheral blood reticulocytes using the micronucleus test following chronic exposure. The results show the effects of lead acetate in peripheral blood reticulocytes. These effects are both cytotoxic and genotoxic because of a decrease in the number of polychromatic erythrocytes in the peripheral blood and an increase in frequency of micronucleated reticulocytes, respectively.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
MutagenesisHome page
A. Balasubramanyam, N. Sailaja, M. Mahboob, M. F. Rahman, S. M. Hussain, and P. Grover
In vivo genotoxicity assessment of aluminium oxide nanomaterials in rat peripheral blood cells using the comet assay and micronucleus test
Mutagenesis, May 1, 2009; 24(3): 245 - 251.
[Abstract] [Full Text] [PDF]


Home page
Toxicol Ind HealthHome page
M. Alghazal, I Sutiakova, N Kovalkovicova, J Legath, M Falis, J Pistl, R Sabo, K Benova, L Sabova, and P Vaczi
Induction of micronuclei in rat bone marrow after chronic exposure to lead acetate trihydrate
Toxicology and Industrial Health, October 1, 2008; 24(9): 587 - 593.
[Abstract] [PDF]


Home page
MutagenesisHome page
A. Celik, O. Ogenler, and U. Comelekoglu
Re: The evaluation of micronucleus frequency by acridine orange fluorescent staining in peripheral blood of rats treated with lead acetate. (Mutagenesis, 20, 411-415, 2005)
Mutagenesis, July 1, 2006; 21(4): 267 - 267.
[Full Text] [PDF]


Home page
MutagenesisHome page
R. J. Proudlock
RE: The evaluation of micronucleus frequency by acridine orange fluorescent staining in peripheral blood of rats treated with lead acetate. (Mutagenesis, 20, 411-415, 2005)
Mutagenesis, July 1, 2006; 21(4): 265 - 265.
[Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.